Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022

BUY
$137.62 - $174.96 $371,711 - $472,566
2,701 Added 147.35%
4,534 $695,000
Q1 2022

Apr 25, 2022

SELL
$131.98 - $163.75 $66,253 - $82,202
-502 Reduced 21.5%
1,833 $297,000
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $250,849 - $317,396
2,335 New
2,335 $316,000
Q2 2021

Jul 28, 2021

SELL
$105.21 - $117.21 $1.73 Million - $1.92 Million
-16,404 Closed
0 $0
Q1 2021

May 24, 2021

BUY
$102.3 - $112.62 $1.68 Million - $1.85 Million
16,404 New
16,404 $1.78 Million
Q1 2021

May 03, 2021

SELL
$102.3 - $112.62 $1.28 Million - $1.41 Million
-12,550 Closed
0 $0
Q4 2020

Jan 21, 2021

SELL
$80.49 - $108.67 $1.66 Million - $2.24 Million
-20,625 Reduced 62.17%
12,550 $1.35 Million
Q3 2020

Nov 02, 2020

SELL
$85.91 - $100.83 $4.82 Million - $5.66 Million
-56,134 Reduced 62.85%
33,175 $2.91 Million
Q2 2020

Aug 07, 2020

BUY
$73.37 - $98.18 $6.01 Million - $8.04 Million
81,879 Added 1102.01%
89,309 $8.77 Million
Q1 2020

May 04, 2020

BUY
$64.5 - $97.79 $479,235 - $726,579
7,430 New
7,430 $566,000
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $5.16 Million - $6.2 Million
-81,903 Closed
0 $0
Q2 2019

Aug 01, 2019

SELL
$65.7 - $83.98 $4.13 Million - $5.28 Million
-62,874 Reduced 43.43%
81,903 $0
Q1 2019

May 01, 2019

BUY
$77.14 - $90.79 $10.1 Million - $11.9 Million
131,278 Added 972.5%
144,777 $0
Q4 2018

Jan 30, 2019

SELL
$77.85 - $96.01 $2.66 Million - $3.28 Million
-34,207 Reduced 71.7%
13,499 $1.24 Million
Q3 2018

Nov 05, 2018

SELL
$88.91 - $98.84 $2.41 Million - $2.68 Million
-27,135 Reduced 36.26%
47,706 $0
Q2 2018

Jul 18, 2018

SELL
$89.78 - $106.23 $1.77 Million - $2.1 Million
-19,722 Reduced 20.86%
74,841 $0
Q1 2018

May 08, 2018

BUY
$92.01 - $123.21 $95,322 - $127,645
1,036 Added 1.11%
94,563 $0
Q4 2017

Feb 06, 2018

SELL
$89.56 - $98.21 $2.12 Million - $2.32 Million
-23,621 Reduced 20.16%
93,527 $0
Q3 2017

Nov 01, 2017

BUY
$69.85 - $89.22 $8.18 Million - $10.5 Million
117,148
117,148 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pendal Group LTD Portfolio

Follow Pendal Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.